Comment on “Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies” and “High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints”
Clinical Pharmacokinetics · 2024
DOI: 10.1007/s40262-024-01357-4 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Pharmacokinetics, 2024. Verfasst von Leping Kong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Critical Illness, Pyridines, Nitriles, Triazoles. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia.
- The University of Sydney Infectious Disease Institute, Sydney, NSW, Australia.
- Department of Pharmacy, Westmead Hospital, Sydney, NSW, Australia.
- Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia. sophie.stocker@sydney.edu.au.
- The University of Sydney Infectious Disease Institute, Sydney, NSW, Australia. sophie.stocker@sydney.edu.au.
- Department of Pharmacy, Westmead Hospital, Sydney, NSW, Australia. sophie.stocker@sydney.edu.au.
ORCID-Profile: Leping Kong, Jan-Willem C Alffenaar, Sophie L Stocker
Zitieren
APA
Kong, L., Alffenaar, J. C., & Stocker, S. L. (2024). Comment on “Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies” and “High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints”. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-024-01357-4
Vancouver
Kong L, Alffenaar JC, Stocker SL. Comment on “Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies” and “High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints”. Clinical Pharmacokinetics. 2024. doi:10.1007/s40262-024-01357-4
BibTeX
@article{Kong2024,
author = {Kong, Leping and Alffenaar, Jan-Willem C and Stocker, Sophie L},
title = {Comment on “Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies” and “High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints”},
journal = {Clinical Pharmacokinetics},
year = {2024},
doi = {10.1007/s40262-024-01357-4}
}
EUVIMED